IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Observational Research in Childhood Infectious Diseases Study (ORChID)
This study has been completed.
Sponsor:
Queensland Children's Medical Research Institute
Collaborator:
Royal Brisbane and Women's Hospital
Information provided by (Responsible Party):
Dr Stephen Lambert, Queensland Children's Medical Research Institute
ClinicalTrials.gov Identifier:
NCT01304914
First received: February 25, 2011
Last updated: March 30, 2016
Last verified: March 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In this study, the investigator will be approaching pregnant women to undertake 2 years of weekly respiratory and nappy specimen collection from their healthy new born infant. These specimens will be mailed to the Queensland Paediatric Infectious Diseases (Qpid) Laboratory where they will be stored and batched tested for viruses and bacteria. As well as this, parents will keep a simple daily symptom diary for their child, allowing us to match detection of viruses and bacteria to periods when the study child did or did not have symptoms. This will help our understanding of what finding these viruses and bacteria in specimens from children really means.
| Condition |
|---|
| Respiratory Tract Infections Gastrointestinal Infections |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Prospective, Community-based, Longitudinal Dynamic Birth Cohort Study of Respiratory and Gastrointestinal Pathogen Identification in Brisbane Infants. |
Further study details as provided by Dr Stephen Lambert, Queensland Children's Medical Research Institute:
Primary Outcome Measures:
- Acute respiratory illness (ARIs) and acute gastrointestinal (AGE) illness rates per 10,000 child-days in healthy children in the first two years of life [ Time Frame: Two years ]This measure will be calculated using counts of ARIs and AGE in study children during the first two years of life as the numerator, and person-time in child-months on the study as the denominator.
Secondary Outcome Measures:
- Pathogen-specific rate of episodes of ARI and AGE per 10,000 child-days in healthy children in the first two years of life [ Time Frame: 2 years ]Viral and bacterial testing will allow to calculate pathogen-specific rates: This measure will be calculated using counts of pathogen-specific ARIs and AGE in study children during the first two years of life as the numerator, and person-time in child-months on the study as the denominator.
- Detection of novel pathogens in healthy children in the first 2 years of life. [ Time Frame: 2 years ]A subset of samples collected during this study will be used to attempt to identify previously undetected pathogens in children, through microarray technology and random primer PCR testing.
Biospecimen Retention: Samples With DNA
Parent-collected anterior-nasal swabs Nappy swabs
| Enrollment: | 165 |
| Study Start Date: | August 2010 |
| Study Completion Date: | November 2014 |
| Primary Completion Date: | November 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Healthy, term-delivered babies |
Show Detailed Description
Eligibility| Ages Eligible for Study: | up to 7 Days (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Healthy, term-delivered babies
Criteria
Inclusion Criteria:
- pregnant women expecting to deliver a healthy, term baby
- written informed consent from pregnant woman who is available for telephone contact for the duration of the study, and not planning to move out of the study area
- parent willing to collect a weekly anterior nasal specimen and stool (nappy) specimen from the study child and return to study site via mail
- parent or guardian with sufficient English language skills to complete study diaries and perform study tasks as required
Exclusion Criteria:
- children born before 36 weeks
- children with chronic pulmonary or cardiovascular disorders
- children with chronic metabolic disorders (such as, but not limited to, diabetes mellitus, renal dysfunction, haemoglobinopathies)
- children with immune system disorders (such as HIV/AIDS or receiving immune system suppressing medications)
- children with other chronic illnesses whose enrollment is deemed by the investigators to make it inappropriate to enroll them onto, or to continue in, the study
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01304914
Please refer to this study by its ClinicalTrials.gov identifier: NCT01304914
Locations
| Australia, Queensland | |
| Royal Brisbane and Women's Hospital | |
| Brisbane, Queensland, Australia, 4029 | |
| Northwest Private Hospital | |
| Everton Park, Queensland, Australia, 4053 | |
Sponsors and Collaborators
Queensland Children's Medical Research Institute
Royal Brisbane and Women's Hospital
Investigators
| Principal Investigator: | Keith Grimwood, MD | Queensland Children's Medical Research Institute |
| Principal Investigator: | Theo P Sloots, PhD | Queensland Children's Medical Research Institute |
| Principal Investigator: | Michael D Nissen, FRACP | Queensland Children's Medical Research Institute |
| Principal Investigator: | Stephen B Lambert, PhD | Queensland Children's Medical Research Institute |
More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Dr Stephen Lambert, Senior Research Fellow, Queensland Children's Medical Research Institute |
| ClinicalTrials.gov Identifier: | NCT01304914 History of Changes |
| Other Study ID Numbers: |
HREC10/QRCH16 |
| Study First Received: | February 25, 2011 |
| Last Updated: | March 30, 2016 |
Keywords provided by Dr Stephen Lambert, Queensland Children's Medical Research Institute:
|
Respiratory tract infections Gastrointestinal tract infections Pediatrics Specimen collection |
Additional relevant MeSH terms:
|
Infection Communicable Diseases Respiratory Tract Infections Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on July 25, 2017